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1. Introduction 
Carbohydrates are the most abundant and structurally diverse class of biological 
compounds in nature. However, our current understanding regarding the relationship 
between carbohydrate structure and its biological function is still far from what is known 
regarding proteins and nucleic acids. Initially, carbohydrates were only recognized as 
structural and energy storage molecules (e.g. cellulose, chitin and glycogen), but recent 
developments in the field have shown that carbohydrates are also involved in numerous 
biological events, such as cancer, inflammations, pathogen infections, cell-to-cell 
communication, etc. In addition, carbohydrate-processing enzymes have become the choice 
in many industrial applications due to their stereo-selectivity and efficiency1.  
Carbohydrates can be found in nature in many forms, from simple monomers to more 
complex oligomers, polymers or glicoconjugates. The complexity of these structures can be 
reasonably high since each carbohydrate monomer can accommodate multiple linkages 
and/or branches in its structure. Moreover, as the glycosidic linkage between each 
monosaccharide can have two anomeric configurations (α or β), even in small 
oligosaccharides, the potential number of structures that can exist is huge. 
In the last decades, there has been a great effort to synthesize oligo- and poly-saccharides in 
the laboratory, mainly due to their key role in many biological events but also to the interest 
expressed by the food and technical industries. The chemical approaches to carbohydrate 
synthesis have been known since Arthur Michael first reported the synthesis of a natural 
glycoside in 18792. However, the construction of complex carbohydrates and 
glycoconjugates in the laboratory remains a challenging endeavor. The causes for these 
difficulties are several but they mainly rely on the exceptional complexity and diversity that 
some compounds may show. Indeed, unlike the systematic processes of proteins and nucleic 
acids synthesis, in which the order of attachment of amino acids and nucleotides is read 
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from a nucleic acid matrix, the synthesis of carbohydrates is a non-template-directed process 
that is controlled by a complex stereo- and regio-specific process. It requires a special 
regioselective reaction at a particular position of the sugar unit, in which the hydroxyl group 
that is available in such position must be distinguished from all the other hydroxyl groups 
in the structure that have similar properties. Additionally, the linkage between sugars must 
proceed through a stereoselective manner, since the linkage can produce two stereoisomers 
and one of them must be preferred to the other. Many carbohydrates are also found linked 
to protein and lipids. The synthesis of glycoconjugates has also proven to be a difficult task 
because it generally involves the participation of multiple transporters and enzymes. The 
mechanisms governing the regulation of these pathways are still being elucidated, but so far 
it has been found that the assembly of carbohydrates to proteins and lipids requires a 
specific chemistry that is far from being universal.  
The production of oligosaccharides and polysaccharides has been deeply studied in the past 
decades and revealed to be, as expected, a challenging task3. In spite of the advances 
observed in organic chemistry, the chemical synthetic routes addressed to synthesize these 
compounds have proven to be inefficient in the majority of the cases. This happens because 
the preparation of complex oligosaccharides and polysaccharides require multiple 
protection/deprotection and purification steps, which often lead to a tedious and time-
consuming process and normally result in poor yields. To overcome these limitations, the 
enzymatic synthesis rapidly gained more prominence. The attractiveness of enzymatic 
synthesis is that protecting groups are not required and the stereo- and regio-selectivity 
chemistry is always followed in the formation of the glycosidic linkages, in the majority of 
the cases. 
Enzymatic formation and cleavage of the bond between two sugars or between a sugar and 
another group can occur by hydrolysis to give the free sugar (glycosidases), by 
transglycosylation to give a new glycoside (glycosyltransferases), by phosphorolysis to give 
the sugar-1-phosphate (phosphorylases) or by elimination to give unsaturated sugar 
products (lyases). Currently, glycosidases and glycosyltransferases are the major classes of 
biocatalysts that are available for the enzymatic synthesis of polysaccharides and 
oligosaccharides.1 As the structure of lysozyme was first solved in 19654, glycosidases have 
long been the subject of structural biology studies in order to understand the molecular 
details of substrate recognition and of catalysis. As a result, about three quarters of the 113 
known families of glycosidases have at least a structural representative. In contrast, progress 
in the structural biology of glycosyltransferases has been slower1. Part of the success in 
characterizing glycosidases is due to the high stability of these enzymes when compared 
with the glycosyltransferases and because they are very easy to isolate, being generally 
available from natural sources like seeds, micro-organisms or fungal cultures, as well as in 
higher organisms (typically plant seed, mollusks, etc)5. These facts have turned glycosidases 
into an attractive target for many industries involved in the food, the paper and pulp 
industry, as well as in organic chemistry, where glycosidases have proven to be extremely 
efficient catalysts, being capable of hydrolyzing the very stable glycosidic bonds in 
glycoconjugates, oligo- and poly-saccharides6. The importance of glycosidases has also 
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attracted the attention of many pharmaceutical industries since they are involved in many 
biological processes such as cell-cell or cell-virus recognition, immune responses, cell 
growth, and viral and parasitic infections. Currently, they have been associated with many 
diseases, which result from the lack or dysfunction of a glycosidase and are used in the 
treatment of metabolic disorders, viral infections and even cancer.  
Despite the current advances in the field and the exponential interest in glycosidases, many 
aspects of the mechanism of action of these enzymes remain hidden in the available 
experimental data, in particularly in the X-ray structures that figure in the protein databank.  
Taking this into account, we focus in this review in the current literature regarding the 
catalytic mechanisms of glycosidases. 
2. Catalytic mechanism of glycosidases 
Glycosidases (GH) are present in almost all living organisms (exceptions are some 
Archaeans and a few unicellular parasitic eukaryotes)7,8 where they play diverse and 
different roles. Taking into account the diversity of reactions that they catalyze as well as 
amino acid sequence and folding, glycosidases have been classified in many different ways. 
According to The IUBMB (International Union of Biochemistry and Molecular Biology) 
glycosidases are classified based on their substrate specificity and/or their molecular 
mechanism.9,10 However, this classification is far from gaining consensus. A necessary 
consequence of the EC classification scheme is that codes can be applied only to enzymes for 
which a function has been biochemically identified. Additionally, certain enzymes can 
catalyse reactions that fall in more than one class, which makes them bear more than one EC 
number. Furthermore, this classification does not reflect the structural features and 
evolutionary relations of enzymes. In order to overcome these limitations, a new type of 
classification was proposed based on the amino acid similarity within the protein. This new 
classification is available at the Carbohydrate-Active Enzymes database (CAZy - 
http://www.cazy.org/)7,10 and provides a direct relationship between sequence and folding 
similarities, that can be found in 130 amino acid sequence-based families. Some families 
with apparently unrelated sequence similarities show some uniformity in their three-
dimensional structures. In those cases, these structures have been assigned to the so-called 
“Clans”, that have been numbered from A to N.7 In general, GHs belonging to the families 
of the same clan have common ancestry, similar 3D structure and are characterized by an 
identical catalytic mechanism of action.7,10-16 
The two most commonly employed mechanisms used by glycosidases to achieve glycosidic 
bond cleavage with overall inversion or retention of anomeric stereochemistry are shown 
schematically at Figure 1. These mechanisms can be generally divided in two main groups: 
the retaining GHs and the inverting GHs. 17,18 Generally, enzymes of the same family have 
the same mechanism (but not specificity) [41, 43, 63], and the only exception are the GH23 
and GH97 families that combine retaining and inverting GHs.19 Table 1 summarizes the 
information about all GHs discovered until now. 
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Figure 1. Mechanistic overview of retaining and inverting GHs activities. 
 
Clan Families (GHs) 
Type of 
Mechanism
Three-dimensional 
structure 
A 7,10,16,20-33 
1, 2, 5, 10, 17, 26, 30, 35, 39, 42, 50,
51, 53, 59, 72, 79, 86, 113, 128 Retaining (β/α)8 barrel 
B 34 7, 16 Retaining β-sandwich 
C 35,36 11, 12 Retaining β-sandwich 
D 37-43 27, 31, 36 Retaining (β/α)8 barrel 
E 7,38 33, 34, 83, 93 Retaining 6-bladed β-propeller 
F 44,45 43, 62 Inverting 5-bladed β-propeller 
G 30 37, 63 Inverting (α/α)6 barrel 
H 46-52 13, 70, 77 Retaining (β/α)8 barrel 
I 7,53-55 24, 46, 80 Inverting α+β lysozyme 
J 26,44,45,56,57 32, 68 Retaining 5-bladed β-propeller 
K 7,25,28,30 18, 20, 85 Retaining (β/α)8 barrel 
L 7,18,32 15, 65, 125 Inverting (α/α)6 barrel 
M 30 8, 48 Inverting (α/α)6 barrel 
N 30,32,58,59 28, 49 Inverting (β)3 solenoid 
Table 1. Organization of glycosidases families in clans and their correlation with the type of 
mechanism that they catalyze, and their protein folding. 
2.1. Retaining GHs 
The catalytic mechanism of retaining glycosidases was proposed about 58 years ago by 
Koshland et al 60 (Figure 2). According to this proposal, the mechanism occurs as a double 
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displacement involving two steps: a glycosylation and a deglycosylation step. In the first 
step, the enzyme is glycosylated by the concerted action of the carboxylates of two residues, 
either Asp or Glu, or both that are found on opposite sides of the enzyme active site and are 
normally close to each other (around 5.5 Å). One of these residues functions as a general 
acid in the first step of the mechanism where the glycosidic bond starts to break. The acid 
residue donates a proton to the dissociated sugar. During the same step, the second 
deprotonated carboxylate acts as a nucleophile, attacking the anomeric carbon at the 
oxocarbenium ion-like transition state. This step, referred to as the glycosylation step, leads 
to the formation of a covalently linked glycosyl-enzyme intermediate that has an anomeric 
configuration opposite to that of the starting material. The second step of this reaction, the 
deglycosylation step, involves the hydrolytic breakdown of the glycosyl-enzyme 
intermediate61. The carboxylate that first functioned as an acid catalyst now acts as a base by 
abstracting a proton from the incoming nucleophile, usually a water molecule. 
Simultaneously, the water molecule attacks the carbohydrate-enzyme linkage in a reverse 
mode of the first step. At the end of the reaction, the enzymatic turnover is obtained and a 
hemi-acetal is formed with the same anomeric configuration as the starting material. Recent 
studies have shown that the transition states (TS1 and TS2) of both glycosylation and 
deglycosylation steps have a dissociative nature. Both reactions are favored by the distortion 
of the substrate during catalysis, but this effect is more evident in the first step of the 
reaction62-65. The glycosylation process is also favored by the hydrogen bond between the 
nucleophilic carboxylate and the hydroxyl group of position 2 in the substrate. It behaves 
almost as an anchor that aligns the substrate in the active site and facilitates the 
glycosylation process.  
 
Figure 2. Catalytic mechanism of retaining GHs. 
A variation of the general mechanism for retaining enzymes has been demonstrated for the 
N-acetyl-β-hexosaminidases, belonging to families 18 and 2066,67. Unlike the most retaining 
glycosidases, these enzymes lack a catalytic nucleophile, e.g. the water molecule. Instead, it 
is the acetamido substituent of the substrate that acts as an intramolecular catalytic 
nucleophile.68-71 As it is shown in Figure 3, the general acid/base residue protonates the 
oxygen of the scissile glycosidic bond. The other charged carboxylate residue stabilizes the 
positive charge developed on the nitrogen of the oxazolinium ion that is formed after the 
intramolecular attack of the N-acetamido oxygen to the anomeric carbon.68,72 To complete 
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the double displacement mechanism, in the second step, an incoming water molecule 
attacks the anomeric carbon, resulting in a product with retention of the initial 
configuration.73 In this reaction, several aromatic residues available in the active site have a 
key role to endorse the correct orientation of the nucleophilic carbonyl oxygen of the 
substrate and in this way promote and stabilize the formation of the oxazolinium ion. 
 
Figure 3. Catalytic mechanism of retaining β-hexosaminidase from families GH18 and GH20. 
2.2. Inverting GHs 
In inverting GHs, there is an inversion of the anomeric configuration of the starting material. 
Here, the two crucial carboxylic residues act as general acid and base catalysts and these 
groups are circa 10.5 Å apart from each other. It this specific case, this distance is larger than 
in retaining GHs because the substrate and the water molecule must be present 
simultaneously in the active site of the enzyme during the hydrolytic process.18,66,74-78 Figure 
4 shows the proposed mechanism of action for inverting GHs, which occurs via a single-
displacement type of mechanism. In this case, one of the carboxylate residues protonates the 
scissile glycosidic oxygen atom while the other coordinates the nucleophile (i.e. the water 
molecule) to assist its deprotonation and in this way complete the hydrolysis reaction.79 
 
Figure 4. Catalytic mechanism of inverting GHs. 
In contrast with the retaining mechanism, this reaction is completed in a single step and it is 
supposed that it requires the formation of a single transition state structure. Moreover, it 
does not involve the formation of any covalent enzyme intermediate during the course of 
catalysis and induces the inversion of the anomeric configuration of the starting material. 
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2.3. Cofactor dependent GHs 
There are other GHs whose catalytic mechanism is substantially different from the 
mechanisms described above. One of the most interesting ones requires the presence of an 
NADH cofactor. The retaining 6-phospho-α-GH enzymes from family 4 are among these 
enzymes (Figure 5) in which the cofactor is perfectly positioned to remove the hydride from 
carbon C3 of the substrate80. Consequently, the acidity of the hydrogen atom that is attached 
to carbon C2 of the substrate increases and helps its abstraction by one of the tyrosine 
residues that is available in the active site and acts as a base. The hydroxyl group that is 
initially attached to carbon C3 of the substrate is subsequently oxidized to a ketone forming 
the 1,2-unsaturated reactive intermediate. Simultaneously, one of the carboxylate residues 
assists the cleavage of the sugar bound and the proton that is attached to carbon C2 of the 
substrate is abstracted by the base. This step is favoured by the presence of a metal ion in the 
active site of the enzyme that polarizes the carbonyl at carbon C3 and stabilizes the enolate 
species. The last step of this mechanism involves the nucleophilic attack of one water 
molecule to the double bond of the ketone. Simultaneously, the re-protonation of the enolate 
is catalysed by the close presence of the tyrosine residue, and the reduction of the ketone 
located at carbon C3 is accomplished by the NADH, favouring the enzymatic turnover.  
 
Figure 5. Catalytic mechanism for NADH dependent GHs. 
2.4. Transglycosylation activity of GHs 
In addition to the hydrolytic ability, GHs can also be used under appropriate conditions for 
the reverse reaction, thus promoting the formation of glycosidic linkages. This type of 
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reactions are called transglycosylation62 and generally require high concentration of 
substrate. The proposed catalytic mechanism is depicted in Figure 6. Similarly to the 
previous described mechanisms, the first step leads to the departure of the aglycon group 
and the formation of the covalent intermediate. The second step of the reaction involves the 
attack of the carbohydrate-enzyme linkage by another sugar molecule, and the proton 
transfer from the sugar to the active site acid/base carboxylate. 
 
Figure 6. Transglycosylation reaction catalyzed by retaining GHs. 
Usually, the synthesis of glycosidic linkages in nature is carried out natively by 
glycosyltransferases (that use activated glycosides as the glycosyl donors). Typical glycoside 
donors are expensive nucleotide sugars such as ADP-glucose, UDP-glucose, and UDP-
galactose. In contrast, the transglycosylation activity of GHs employs a considerably 
inexpensive substrate (such as simple sugars) as a glycoside donor molecule leading to large 
industrial interest in employing these enzymes for biotechnological synthesis. However, the 
yields for these transglycosylation reactions are typically low because the product itself is a 
substrate for the enzyme and undergoes hydrolysis. As their hydrolytic activities compete 
with this mechanistic pathway, it is necessary to displace the equilibrium of the glycosidic 
bond formation using excessive substrate concentration (thermodynamic control) or using 
good activated glycosyl donors, such as an aryl glycoside (kinetic control). Another 
disadvantage of the transglycosylation reactions catalysed by GHs is their limited efficiency 
for the glycosides synthesis in disaccharides or trisaccharides.3,81 This happens because these 
reactions require high degrees of chemo, regio and stereo-selectivity.82 The same is also true 
for oligosaccharides, but in this case the problems arise from their complex structure turning 
their chemical synthesis difficult to achieve, namely the production of glycosides with a 
mixture of various linkages (i.e., formation of 1-2, 1-3, 1-4 and 1-6 glycosidic bonds) and 
both anomers (α and β).83 In this regard, the control of the stereospecificity and the 
regiospecificity of bond formation remains a challenging problem in the chemical synthesis 
of oligosaccharides 84,85. A solution for this unsolved problem would be very important, as 
industrially there is only interest in the oligosaccharide target. 
In order to overcome most of the limitations of the transglycosylation reaction in 
glycosidases, many enzymes have been mutated in the region of the active site in order to 
enhance the rate of this reaction. A classical example of mutated glycosidases are the 
glycosynthases, in which the hydrolytic activity has been inactivated through the mutation 
of their catalytic nucleophile residues by small non-nucleophilic residues, such as alanine, 
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glycine or serine These enzymes possess a high activity because they are able to accept an 
activated glycosyl donor group (generally glycosyl fluorides or nitrophenyl glycosides) and 
catalyse transglycosylation reactions to an acceptor molecule.81,85 In opposition to the native 
GHs, these engineered enzymes produce carbohydrates with elevated molecular weight and 
with higher product yields.81 The first glycosynthase enzyme was reported in 1998 by 
Withers and colleagues86 but, currently many other glycosynthases have been developed 
that posses specific substrate specificity. Figure 7 shows the reaction mechanisms of several 
types of glycosynthases. As native glycosidases, the glycosynthases can also show retaining 
and inverting mechanism. In the inverting α-glycosynthases, the donor group is transferred  
 
Figure 7. Catalytic mechanism of glycosynthases: a) inverting β-glycosynthase, b) retaining β-
glycosynthase, c) inverting α-glycosynthase and d) thioglycoligase. 
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to the 4-nitrophenyl-α-glucoside acceptor group and the deglycosylation step proceeds 
similarly to what is observed with the retaining GHs (Figure 7a). The retaining 
glycosynthases act within the presence of one external nucleophile, such as sodium formate, 
and an activated donor group with the anomeric configuration of the native substrate 
(commonly 2-nitrophenyl- or 2,4-dinitrophenyl-β-glucoside) (Figure 7b). Therefore, the 
nucleophile mimics the catalytic active-site carboxylate of the enzyme and builds the 
formyl-glycoside intermediate. Subsequently, the donor carbohydrate is transferred to an 
acceptor sugar, promoting the polysaccharide synthesis.85,87-90  
Some retaining glycosynthases can also have inverting mechanisms. This occurs when the 
donor sugar has a glucosyl fluoride in an opposite anomeric configuration relatively to the 
native substrate, thus mimicking the intermediate of the reaction (Figures 7a and 7c).86 
Another type of glycosynthases are the thioglycoligase engineering enzymes, in which the 
mutated residue is the acid/base carboxylate instead of the nucleophile residue as in the 
previously described glycosynthases (Figure 7d). In these cases, a good leaving group such 
as dinitrophenyl, is placed in the substrate, which allows the formation of the glycosyl-
enzyme intermediates that favors the catalytic process.91  
3. Structural aspects that influence the GHs catalytic mechanism  
The structural studies addressed at GHs have also provided important clues about how 
these enzymes enhance the catalytic process. As mentioned before, the distortion of the 
substrate along the full catalytic process is one of these mechanisms and this effect is found 
in many studies.92-99 The available data reveals that GHs are able to selectively bind and 
stabilize high energy substrate conformations before the hydrolysis takes place. Such 
distortion of the substrate favours, in the Michaelis complex, the attack of the catalytic 
acid/base carboxylates to the glycosidic oxygen of the substrate. At the same time, it helps to 
guide the leaving group in a pseudoaxial position in relation to the substrate, facilitating the 
nucleophilic attack on carbon C1 and the subsequent cleavage of the glycosidic bond. It has 
been proposed also that the conformation changes of the ring along the catalytic process 
might determine the efficiency of the polysaccharides degradation. Taking into account 
these results and the available X-ray structures of several GHs that contain the substrates 
with different conformational distortions, Stoddart 100-102 proposed a diagram to classify the 
conformation of a α-glucopyranose molecule ring along the reaction pathway (Figure 8). In 
this diagram C, B, S corresponds to the chair, boat, and skew conformations, respectively. 
This diagram includes the most energetically stable 4C1 chair, six boat-type and six skew-
type conformations, as well as several transient structures (e.g. half-chair and envelope 
conformations) between the transition of 4C1 chair to the boat/skew conformations.  
The itinerary map of Stoddart gives therefore all the possible conformational pathways that 
a hypothetical substrate may follow as it moves from one conformation to another94. 
However, no energetically information can be extracted regarding the relative stability of 
different conformations, nor can it be assumed that all conformations on this map 
correspond to stationary points in the free energy landscape with respect to ring distortion.  
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Figure 8. Stoddart’s diagram. 
Nevertheless, over the years, this diagram has been actively used as an “itinerary map” to 
design new enzyme inhibitors for therapeutic activities. In this regard, the conformational 
itinerary pathway of several GHs families has been studied, such as GH29 enzymes and α-
xylosidases from the GH31 family that catalyze the hydrolysis using the 4C1 ↔ 3H4 ↔ 3S1 
glycosylation itinerary 93,103; inverting endoglucanases from the GH8 family that use the β-
2S0/2,5B ↔ 2,5B ↔ α-5S1 glycosylation itinerary of the glycon ring 104; the glycosylation reaction 
of golgi α-mannosidase II from the GH38 family following an 0S2/B2,5 ↔ B2,5 ↔ 1S5 itinerary 
105; the catalytic itinerary of 1,3-1,4-β-glucanase from the GH16 family 16 pursue the 1,4B/1S3 
↔ 4E/4H3 ↔ 4C1 95,106 itinerary, and the inverting α-mannosidases from the GH47 family that 
follow the 3S1 ↔ 3H4 ↔ 4C1 glycosylation itinerary.107 
Many GHs also contain cations in the region of the active site. The presence of these species 
in the structure of GHs appears to be more common than it was initially imagined, and are 
believed to be very important for the stabilization of the transition states during catalysis. 
For instance, the Golgi α-mannosidase II from the GH38 family has a zinc ion in its 3D 
structure. Studies on the catalytic mechanism of this enzyme revealed that the Zn2+ ion is 
fundamental to coordinate the hydroxyl groups attached to carbons C2 and C3 of the 
mannosyl group, which stabilize the transition states, and thus reduces the overall 
activation energy required for the reaction. Furthermore, QM/MM metadynamics 
simulations also demonstrate that the zinc ion helps to lengthen the C2 hydroxyl bond when 
the substrate acquires the oxocarbenium character, facilitating the electron reduction of this 
species.105 A similar role has been proposed for the calcium ion present in the structure of 
the endoplasmic reticulum α-mannosidase I from the GH47 family. The crystallographic 
structure shows that the cation coordinates with the hydroxyl groups that are attached to 
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carbons C2 and C3 of 1-deoxymannojirimycin or kifunensin inhibitors.108 A magnesium ion 
is also found close to the region of the active site of β-galactosidase from Escherichia coli. In 
these case, theoretical calculations have clearly demonstrated that the presence of the cation 
has a key role in lowering down the activation barrier by 14.9 kcal/mol, emphasizing its 
importance during the catalytic process.63 
4. Conclusions 
GHs are impressive nano-molecular machines that are present in almost all living organisms 
(exceptions are some Archaeans and a few unicellular parasitic eukaryotes). These enzymes 
catalyze the hydrolysis of the glycosidic linkage in a myriad of biological reactions and 
under specific conditions can also catalyse the reverse reaction promoting the formation of 
glycoside linkages. 
The interest of GHs has started long ago but the catalytic power behind glycosidases is only 
now being established. Structural analyses of various enzyme complexes representing stable 
intermediates along the reaction coordinate together with detailed mechanistic and 
spectroscopic studies on wild type and mutant enzymes, have revealed that the source for 
their catalytic power is based on nucleophilic and general acid/base catalysis. These 
enzymes develop finely tuned active sites that contain two carboxylates residues (Asp and 
Glu) carefully aligned and positioned on opposite sides of the enzyme active site that 
embrace the substrate upon substrate binding. The active site also provides an extensive 
network of hydrogen bonds that endorse a conformational distortion of the substrate. This 
induces the substrate to adopt a higher energetic conformation before the hydrolysis takes 
place, and such configuration is maintained during the full catalytic process. This effect is 
very important for the stabilization of the transition-state structure and therefore to lower 
the activation barrier of the full process. Some GHs also possess positive ions (Zn2+, Mn2+, 
and Mg2+) into their structure and these cations have been found also to be essential for the 
stabilization of the transition states during catalysis. The two most commonly employed 
mechanisms used to hydrolyze the glycoside linkage of substrates by glycosidases involve 
the retention or the inversion mechanisms. These mechanisms are conserved within the 
majority of GHs families. The only exception are the glycosidases from family 4 and 109, in 
which the hydrolytic process occurs via an elimination type of mechanism, and requires the 
presence of the NADH cofactor.  
The structural and the mechanistic studies addressed to glycosidases provided and continue 
to provide important clues about the catalytic power of these enzymes. This knowledge is 
very important as it offers new ways to improve, modify or even inhibit the activity of GHs. 
These developments are particularly important for the biotechnology industries that have 
been increasing the commercial uses of glycosidases in several areas. Indeed, specific 
glycosidases are increasingly used for food processing, for bio-bleaching in the pulp and 
paper industry, as well as for biomass degradation with the potential to convert solid 
biomass into liquid fuels.  
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In the last two decades, it has also been watched an increasing interest of glycosidases for 
therapeutic uses. Glycosidases are involved in the biosynthesis of the oligosaccharide chains 
and quality control mechanisms in the endoplasmic reticulum of the N-linked glycoproteins. 
Inhibition of these glycosidases can have profound effects on quality control, maturation, 
transport, and secretion of glycoproteins and can alter cell–cell or cell–virus recognition 
processes. This principle is the basis for the potential use of glycosidase inhibitors in viral 
infection, diabetes and genetic disorders. 109,110. Most of these drugs are glycosidase 
inhibitors that can bind and block the active sites of these enzymes. Some successful 
examples are the α-amylase inhibitor Acarbose and Miglitol that were approved by the FDA 
in 1990 and 1996, respectively, and are used to inhibit some of the intestinal glycosidases 
and pancreatic α-amylase in order to regulate the absorption of carbohydrates. These 
inhibitors are currently used therapeutically in the oral treatment of the non-insulin-
dependent diabetes mellitus (typr II diabetes). Other glycosidases inhibitors are used as 
anti-viral agents111. Here the inhibitors were developed to inhibit the formation of 
glycoproteins of the viral envelopes, which are essential for virion assembly and secretion 
and/or infectivity. A successful example was the development of Zanamivir(Relenza) and 
Oseltamivir (Tamiglu), approved by FDA in 1999, that are used in the treatment and 
prophylaxis of influenza caused by influenza A virus and influenza B virus112. These 
compounds efficiently inhibit a glycosidases called neuraminidase. Glycosidases are also 
used in the therapy of human genetic disorders. The glycosphingolipid storage diseases 
(GSD, also glycogenosis and dextrinosis) are a rare hereditary disorders that are severe in 
nature and frequently fatal. These diseases result from defects in the processing of glycogen 
synthesis or breakdown within muscles, liver, and other cell types113. An example of such 
disorders is the Fabry disease that is caused by the deficiency of the essential enzyme α-
glycosidase A, resulting in renal failure along with premature myocardial infarction and 
strokes. The only successful treatment is, to date, the enzyme replacement therapy. 
Fabrazyme was approved by FDA in 2003 and is intended to replace the missing enzyme in 
patients with this progressive disease. 
Taking into account that almost two-thirds of all carbon that exist in the biosphere is 
carbohydrate, we believe that the current applications of GHs are only a small group of the 
many very important applications that these enzymes may find in the future. It is therefore 
expected that a wide variety of relevant and new applications will arise in the near future 
involving glycosidases. To stimulate these developments, the continuous study regarding 
glycosidases will be very important as they will provided crucial knowledge to turn their 
use more efficient and effective. 
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